المؤلفون: Subbiah IM; Department of Investigational Cancer Therapeutics. isubbiah@mdanderson.org, Subbiah V, Tsimberidou AM, Naing A, Kaseb AO, Javle M, Fu S, Hong DS, Piha-Paul S, Wheler JJ, Hess KR, Janku F, Falchook GS, Wolff RA, Kurzrock R

المصدر: Oncotarget [Oncotarget] 2013 Jan; Vol. 4 (1), pp. 156-65.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Bile Duct Neoplasms/*drug therapy , Bile Ducts, Intrahepatic/*drug effects , Cholangiocarcinoma/*drug therapy , Gallbladder Neoplasms/*drug therapy, Adult ; Aged ; Analysis of Variance ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Arteriovenous Fistula/chemically induced ; Bile Duct Neoplasms/pathology ; Bile Ducts, Intrahepatic/pathology ; Cholangiocarcinoma/pathology ; Disease-Free Survival ; Female ; Gallbladder Neoplasms/pathology ; Gastrointestinal Hemorrhage/chemically induced ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Organoplatinum Compounds/administration & dosage ; Organoplatinum Compounds/adverse effects ; Oxaliplatin ; Treatment Outcome